Latest news for Predictive Discovery (OTC:PDIYF) Stock

Predictive Discovery Ltd is a mineral exploration company operating in Australia that focuses on identifying and developing economic reserves in West Africa and Australia. The projects of the company include Bankan Project, Bobosso Project; Ferkessedougou North Project; and many more. Its segment consists of Gold Burk. Faso, Gold Cote D'Ivoire, Gold Guinea, and Corporate.

PREDICTIVE DISCOVERY LTD by Predictive Discovery Ltd.

Predictive Discovery Ltd

News

MRVL

Marvell Teralynx 10 Switch Now Available In Linux Foundation's Open-Source SONiC; Enables Deployment Of 51.2 Tbps Ethernet Switch In Open Network Platforms

<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.tetratech.com%2F&amp;esheet=54099284&amp;newsitemid=20240724906694&amp;lan=en-US&amp;anchor=Tetra+Tech%2C+Inc.&amp;index=1&amp;md5=b51b5814203a7d6c33a0a2a88d101ef4">Tetra Tech, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), a leading provider of high-end consulting and engineering services in water, environment and sustainable infrastructure, announced today that the U.S. Department of Defense (DoD) Environmental Security Technology Certification Program selected the Company and its partner Texas A&amp;M University (TAMU) to design, fabricate, and demonstrate a prototype mobile electron beam (eBeam) system for on-site treatment of soils and sediments impacted by per- and polyfluoroalkyl substances (PFAS).</p>


TTEK

Tetra Tech Selected By DoD Environmental Security Technology Certification Program To Design And Test Mobile Treatment Technology For PFAS-Impacted Soils And Sediments

<p>The Cullen/Frost board declared a&nbsp;third-quarter&nbsp;cash dividend of&nbsp;$0.95&nbsp;per common share, representing a&nbsp;3.3 percent&nbsp;increase compared to the previous quarterly dividend of&nbsp;$0.92&nbsp;per share. The dividend on common stock is payable&nbsp;September 13, 2024&nbsp;to shareholders of record on&nbsp;August 30&nbsp;of this year.</p>


Dividends

Cullen/Frost Bankers Declared A Q3 Dividend Per Share Of $0.95 Vs Prior Quarterly Dividend Of $0.92

<p>SU Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUGP#NASDAQ">SUGP</a>) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today announced it was awarded a material new order at the Hong Kong International Airport (HKIA), increasing market share and position as a leading one-stop security-related services provider. The Hong Kong International Airport is recognized as one of the world's busiest airports and one of the most popular Asian hubs for regional and international travel, and commercial transport. Financial terms were not disclosed but the Company noted it expects this to have a positive material impact on its sales growth.</p>


Contracts

SUGP

SU Group Awarded Material New Order At Hong Kong International Airport; No Financial Terms Disclosed

<p>Canaccord Genuity  analyst David Hynes   maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $835 to $850.</p>


Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on ServiceNow, Raises Price Target to $850

SXTP

60 Degrees Pharmaceuticals Awarded Contract With U.S. Army To Validate New ARAKODA Packaging; Q1 2024 ARAKODA Sales Revenue Up 515% YoY To $105.7K; Increased Commercial Batch Size In Anticipation Of Higher Sales Volume

Earnings

Earnings Beats

Cullen/Frost Bankers Q2 2024 GAAP EPS $2.21 Beats $2.07 Estimate, Sales $528.811M Beat $515.357M Estimate

<p>AGCO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced it has entered into a definitive agreement to sell the majority of its Grain &amp; Protein business to American Industrial Partners ("AIP") in an all-cash transaction valued at $700 million, subject to working capital and other customary closing adjustments.</p>


Asset Sales

AGCO

AGCO Announces Definitive Agreement To Sell Its Grain & Protein Business In An All-Cash Transaction Valued At $700M

<p><strong>LiqTech International, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems for marine, and Danbee Marine,&nbsp;a South Korean-based maritime representative to the shipping industry, entered into a partnership agreement with Danbee to market LiqTech's marine scrubber water treatment solutions within South Korea, the second largest ship building market in the world after China.</p>


Global

LIQT

LiqTech And Danbee Marine Co. Ltd. Enter Agreement For Marine Scrubber Water Treatment Solutions For The South Korean Market

<p><strong>EW: -24% &#x7C; </strong><a href="https://www.benzinga.com//node/39952400">Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 guidance below estimates. Also, the company acquired JenaValve and Endotronix.</a></p>
<p>&nbsp;</p>
<p><strong>MXL: -27% &#x7C; </strong><a href="https://www.benzinga.com//node/39952857">MaxLinear shares are trading lower after the company reported worse-than-expected Q2 financial results.</a></p>
<p>&nbsp;</p>
<p><strong>&nbsp;POAI: 117% &#x7C; </strong><a href="https://www.benzinga.com//node/39953717">Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results</a></p>


Movers

Trading Ideas

POAI

Market-Moving News for July 25th

GLYC

GlycoMimetics To Conduct Additional Clinical Trial For Uproleselan In R/R Acute Myeloid Leukemia After FDA Meeting; Initiates Strategic Review And Corporate Restructuring, Reducing Workforce By 80%; Engages Lucid Capital Markets As Strategic Advisor; Advancing Phase 2/3 Study Of Uproleselan In Newly Diagnosed AML Patients With NCI And Alliance For Clinical Trials; Cash Expected To Fund Company Into Q2 2025

<p>Canaccord Genuity  analyst William Plovanic   maintains Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) with a Hold and lowers the price target from $85 to $77.</p>


Canaccord Genuity Maintains Hold on Edwards Lifesciences, Lowers Price Target to $77

<p><i><strong>Agreement provides Ohio community banks a commercial and industrial loan-acquisition and risk-management program</strong></i></p>
<p>Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>), and OBL BankServices, Inc. (OBLBS), a subsidiary of the Ohio Bankers League, announced today they have entered into a commercial and industrial (C&amp;I) loan growth partnership program known as the Voya Senior Loan Bank Advisory Program.</p>
<p>While community and small regional banks have historically excelled at small business underwriting and relationship management, Voya's C&amp;I program recognizes the syndicated loan market demands a broader industry knowledge and timely action. Participating commercial banks benefit from Voya's unique market leadership, experience, relationships, credit risk management, training and sourcing capabilities while effectively keeping independent research and decision-making within their walls, thus satisfying regulatory requirements.</p>


VOYA

Voya Investment Management And OBL BankServices Enter Into A Commercial And Industrial Loan Growth Partnership Program Known As The Voya Senior Loan Bank Advisory Program.

<p>In the preceding three months, 4 analysts have released ratings for Jones Lang LaSalle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JLL#NYSE">JLL</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $227.5, a high estimate of $240.00, and a low estimate of $200.00. This current average has increased by 9.64% from the previous average price target of $207.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721912479_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Jones Lang LaSalle among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$240.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Alex Kramm</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$240.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$230.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Jones Lang LaSalle. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Jones Lang LaSalle compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Jones Lang LaSalle's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Jones Lang LaSalle's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/JLL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Jones Lang LaSalle analyst ratings.</strong></a></p>
<h2>Discovering Jones Lang LaSalle: A Closer Look</h2>
<p>Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.</p>
<h3>Breaking Down Jones Lang LaSalle's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Jones Lang LaSalle's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>8.67%</strong> as of 31 March, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>1.29%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Jones Lang LaSalle's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.05%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Jones Lang LaSalle's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.42%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Jones Lang LaSalle's debt-to-equity ratio is below the industry average. With a ratio of <b>0.56</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


4 Analysts Assess Jones Lang LaSalle: What You Need To Know

<p>8 analysts have shared their evaluations of AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $22.0, a high estimate of $26.00, and a low estimate of $18.00. This current average has increased by 3.0% from the previous average price target of $21.36. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721912469_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive AT&amp;T. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kannan Venkateshwar</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Maher Yaghi</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$23.00</td>
<td>$22.50</td>
</tr>
<tr>
<td>Jonathan Atkin</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>James Schneider</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$22.00</td>
<td>-</td>
</tr>
<tr>
<td>Bryan Kraft</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Timothy Horan</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>John Hodulik</td>
<td>UBS</td>
<td>Maintains</td>
<td>Buy</td>
<td>$24.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Kannan Venkateshwar</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AT&amp;T. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AT&amp;T compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for AT&amp;T's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of AT&amp;T's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/T/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on AT&amp;T analyst ratings.</strong></a></p>
<h2>About AT&amp;T</h2>
<p>The wireless business contributes about two thirds of AT&amp;T's revenue. The firm is the third-largest US wireless carrier, connecting 72 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 16% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 11% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&amp;T also has a sizable presence in Mexico, with 22 million customers, but this business only accounts for 3% of revenue. The firm still holds a 70% equity stake in satellite television provider DirecTV but does not consolidate this business in its financial statements.</p>
<h3>Understanding the Numbers: AT&amp;T's Finances</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> AT&amp;T's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately <strong>-0.37%</strong>. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> AT&amp;T's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>11.31%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> AT&amp;T's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>3.27%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> AT&amp;T's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.84%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> AT&amp;T's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.44</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


8 Analysts Assess AT&T: What You Need To Know

<p>Allegion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLE#NYSE">ALLE</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $117.5, with a high estimate of $125.00 and a low estimate of $112.00. Experiencing a 4.28% decline, the current average is now lower than the previous average price target of $122.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721912456_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The standing of Allegion among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$117.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$112.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$125.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$116.00</td>
<td>$122.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Allegion. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Allegion compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Allegion's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Allegion's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALLE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Allegion analyst ratings.</strong></a></p>
<h2>All You Need to Know About Allegion</h2>
<p>Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2023, Allegion generated 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy and Switzerland-based Dormakaba.</p>
<h3>Key Indicators: Allegion's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Allegion faced challenges, resulting in a decline of approximately <strong>-3.15%</strong> in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> Allegion's net margin excels beyond industry benchmarks, reaching <strong>13.85%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Allegion's ROE excels beyond industry benchmarks, reaching <strong>9.28%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Allegion's ROA excels beyond industry benchmarks, reaching <strong>2.88%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Allegion's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.49</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ALLE

Expert Outlook: Allegion Through The Eyes Of 4 Analysts

<p>The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies. `</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to B<a href="https://pro.benzinga.com/">enzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Conn&#8217;s Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CONN#NASDAQ">CONN</a>)</strong></h3>
<ul>
<li>On June 26, Conn's received a delinquency notification letter from the Nasdaq. The company's stock fell around 48% over the past five days and has a <a href="https://www.benzinga.com/quote/CONN">52-week low of $0.31</a>.</li>
<li><strong>RSI Value:</strong> 17.61</li>
<li><strong>CONN Price Action:</strong> Shares of Conn&#8217;s closed at $0.35 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072524&amp;t=be2bearmibe3na1">latest CONN news</a>.</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="689" height="729" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085821/Screenshot-2024-07-25-at-6.28.15-PM.png" alt="" class="wp-image-456773" style="width:422px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085821/Screenshot-2024-07-25-at-6.28.15-PM.png 689w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085821/Screenshot-2024-07-25-at-6.28.15-PM-284x300.png 284w" sizes="(max-width: 689px) 100vw, 689px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Levi Strauss &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>)&nbsp;</strong></h3>
<ul>
<li>On June 26, Levi Strauss reported quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 11 cents. "We delivered another strong quarter driven by the Levi's brand's prominence at the center of culture, a robust pipeline of newness and innovation, and continued momentum in our global direct-to-consumer channel. Our amplified focus on women's and denim lifestyle is delivering outsized growth and driving meaningful market share gains," said Michelle Gass, CEO of Levi Strauss &amp; Co. The company's stock fell around 24% over the past month. It <a href="https://www.benzinga.com/quote/LEVI">has a 52-week low</a> of $12.42.</li>
<li><strong>RSI Value:</strong> 25.55</li>
<li><strong>LEVI Price Action:</strong> Shares of Levi Strauss fell slightly to close at $17.50 on Wednesday.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072524&amp;t=be2bearmibe3na1">trend in LEVI stock</a>.</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="688" height="755" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085929/Screenshot-2024-07-25-at-6.29.22-PM.png" alt="" class="wp-image-456777" style="width:432px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085929/Screenshot-2024-07-25-at-6.29.22-PM.png 688w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25085929/Screenshot-2024-07-25-at-6.29.22-PM-273x300.png 273w" sizes="(max-width: 688px) 100vw, 688px" /></a></figure></p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/07/39950906/nasdaq-s-p-500-record-worst-session-since-2022-amid-tesla-alphabet-selloff-investor-optimism-decrea">Nasdaq, S&amp;P 500 Record Worst Session Since 2022 Amid Tesla, Alphabet Selloff: Investor Optimism Decreases Further</a></strong></li>
</ul>


Long Ideas

Markets

CONN

LEVI

Top 2 Consumer Stocks Which Could Rescue Your Portfolio In Q3

<p>On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money">Mad Money Lightning Round</a>,&#8221; <strong>Jim Cramer</strong> said <strong>Jumia Technologies AG</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NYSE">JMIA</a>) is not making a <a href="https://www.benzinga.com/quote/JMIA/earnings">lot of money.</a></p>
<p>The company will release results for the second quarter before the opening bell on Tuesday, Aug. 6.</p>
<p>Benchmark analyst Fawne Jiang initiated coverage of Jumia&#8217;s stock on July 9 with a Buy rating and a $14 price target. The African e-commerce company is poised to benefit from multi-year and potentially multi-decade e-commerce growth in the region.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/etfs/specialty-etfs/23/03/31299793/exclusive-jim-cramer-recommended-svb-financial-in-february-an-example-of-his-reverse-midas-to">Jim Cramer Recommended This Bank A Month Before It Collapsed, An Example Of &#8216;His Reverse Midas Touch&#8217;</a></strong></p>
<p>When asked about <strong>Adeia Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>), he said, &#8220;I would actually put Trade, TTD, which was down very badly today off of Alphabet, and I think that's the one you want to buy.&#8221;</p>
<p>Adeia will announce its financial results for the second quarter on Tuesday, Aug. 6, after the closing bell. Analysts expect the company to report quarterly earnings at 23 cents per share on revenue of $84.25 million.</p>
<p>The &#8220;Mad Money&#8221; host said he likes <strong>Broadcom Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>). &#8220;I think it's absolutely terrific. It's going to get hammered along with the rest of the rotation,&#8221; he added.</p>
<p>On July 17, Cantor Fitzgerald analyst C J Muse maintained Broadcom with an Overweight rating, while adjusting target to $200 from $2,000 (10-1 stock split).</p>
<p>&#8220;I've always been a believer in the gold stocks,&#8221; Cramer said when asked about <strong>Hecla Mining Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>). &#8220;It's not always worked out, but right now it is. Yours is good.&#8221;</p>
<p>Hecla Mining will release its second quarter operational and financial results after the closing bell on Aug. 6. Analysts expect the company to report quarterly earnings at 4 cents per share on revenue of $219.2 million.</p>
<p>Cramer recommended buying <strong>AeroVironment, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>). &#8220;All I know is that drones work,&#8221; he noted.</p>
<p>On July 23, René Carbone Bardorf joined AeroVironment (AV) as Vice President of Marketing and Communications.</p>
<p><strong>Price Action:</strong></p>
<ul>
<li>Adeia shares fell 3.6% to settle at $11.38 on Wednesday.</li>
<li>Hecla Mining shares fell 1% to settle at $5.88.</li>
<li>Jumia dipped 11.3% to close at $12.24 during Wednesday's session.</li>
<li>AeroVironment shares slipped 0.7% to settle at $170.31.</li>
<li>Broadcom shares fell 7.6% to settle at $151.34 on Wednesday.</li>
</ul>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/07/39931967/nvidia-mcdonalds-and-2-other-stocks-insiders-are-selling">Nvidia, McDonald&#8217;s And 2 Other Stocks Insiders Are Selling</a></strong></li>
</ul>


Media

ADEA

AVAV

AVGO

JMIA

Jim Cramer: This Tech Stock Is 'Absolutely Terrific,' But Jumia? It's Not Making A Lot Of Money

<p>Analysts' ratings for NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) over the last quarter vary from bullish to bearish, as provided by 16 analysts.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $273.94, with a high estimate of $346.00 and a low estimate of $213.00. A 8.54% drop is evident in the current average compared to the previous average price target of $299.53. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721912445_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive NICE. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tavy Rosner</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$286.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$213.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Hamza Fodderwala</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$240.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Michael Latimore</td>
<td>Northland Capital Markets</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$305.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$346.00</td>
<td>$339.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$250.00</td>
<td>-</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$225.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$265.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$230.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$300.00</td>
<td>$343.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Buy</td>
<td>$280.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Michael Funk</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$343.00</td>
<td>$343.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NICE. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of NICE compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>For valuable insights into NICE's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NICE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on NICE analyst ratings.</strong></a></p>
<h2>Discovering NICE: A Closer Look</h2>
<p>Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.</p>
<h3>Key Indicators: NICE's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining NICE's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>15.29%</strong> as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> NICE's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>16.13%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> NICE's ROE excels beyond industry benchmarks, reaching <strong>3.13%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> NICE's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.09%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.17</strong>, NICE adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Predictive Discovery

News

Latest news for Predictive Discovery (OTC:PDIYF) Stock